Abstract: This disclosure describes compounds of Formula (I), stereoisomers, side compounds thereof, pharmaceutical compositions and methods of manufacturing such compounds, using silylation reagents and producing compositions and products made using such methods. More particularly, this disclosure describes manufacture of trofinetide and side products, compositions and products containing such compounds, for pharmaceutical uses to treat neurodegenerative or neurodevelopmental disorders.

Abstract: A biomedical electrode for electrically contacting a user's skin includes a carrier layer, a backing layer, an electrical lead, a conductive member, and a gel contact member. The backing layer is disposed on the carrier layer. The electrical lead is positioned at least in part below the carrier layer. The conductive member is coupled to the electrical lead. The gel contact member is electrically coupled to the conductive member for directly contacting the user's skin. The gel contact member is electrically conductive. The gel contact member includes a gel combined with an anti-microbial agent.

Abstract: A biomedical electrode for electrically contacting a user’s skin includes a carrier layer, a backing layer, an electrical lead, a conductive member, and a gel contact member. The backing layer is disposed on the carrier layer. The electrical lead is positioned at least in part below the carrier layer. The conductive member is coupled to the electrical lead. The gel contact member is electrically coupled to the conductive member for directly contacting the user’s skin. The gel contact member is electrically conductive.

Abstract: The present invention is a pyrotechnic time delay system that is improved over prior-art designs. Specifically, the system described herein comprises at least one delay element. The delay element or delay elements each have an input charge, a delay composition, and an output charge. Both the input charge and the output charge are igniter compositions and are comprised of the same components despite having different functional goals. The input charge and output charge compositions preferably contain titanium, manganese dioxide, and polytetrafluoroethylene. The delay composition may be modified from current formulations to include manganese and manganese dioxide, or tungsten and manganese dioxide. The system disclosed herein may be comprised of one delay element, or it may be modular wherein multiple delay elements are connected in series.

Abstract: Provided herein are synthetic analogs of withanolide natural products and their pharmaceutical uses in treating neurodegenerative diseases.

Abstract: The present invention is a pyrotechnic time delay system that is improved over prior-art designs. Specifically, the system described herein comprises at least one delay element. The delay element or delay elements each have an input charge, a delay composition, and an output charge. Both the input charge and the output charge are igniter compositions and are comprised of the same components despite having different functional goals. The input charge and output charge compositions preferably contain titanium, manganese dioxide, and polytetrafluoroethylene. The delay composition may be modified from current formulations to include manganese and manganese dioxide, or tungsten and manganese dioxide. The system disclosed herein may be comprised of one delay element, or it may be modular wherein multiple delay elements are connected in series.

Abstract: Provided herein are synthetic analogs of withanolide natural products and their pharmaceutical uses in treating neurodegenerative diseases.

Abstract: A biomedical electrode for electrically contacting a user's skin includes a carrier layer, a backing layer, an electrical lead, a conductive member, and a gel contact member. The backing layer is disposed on the carrier layer. The electrical lead is positioned at least in part below the carrier layer. The conductive member is coupled to the electrical lead. The gel contact member is electrically coupled to the conductive member for directly contacting the user's skin. The gel contact member is electrically conductive.

Abstract: Provided herein are synthetic analogs of withanolide natural products and their pharmaceutical uses in treating neurodegenerative diseases.

Abstract: Provided herein are synthetic analogs of withanolide natural products of formula (I), wherein R1-R4 are as defined herein, and their pharmaceutical uses in treating neurodegenerative diseases.

Abstract: Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; and optionally, 4) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.

Abstract: Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; and optionally, 4) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.

Abstract: Provided herein are synthetic analogs of withanolide natural products of formula (I), wherein R1-R4 are as defined herein, and their pharmaceutical uses in treating neurodegenerative diseases.

Abstract: Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; and optionally, 4) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.

Abstract: Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; and optionally, 4) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.

Abstract: A method and a corresponding system for obtaining a serum mid-infrared spectroscopic profile using Fourier-transform infrared spectroscopy (FTIR) are described. The method comprises acquiring FTIR spectra for dried sera and preprocessing the FTIR spectra of sera by differentiation and smoothing to enhance weak spectral features and to remove baseline variations. The preprocessed FTIR spectra are normalized to a common intensity range, the normalization being performed in a spectral sub-region defined by strongest infrared (IR) absorption for a protein to obtain the serum spectroscopic profile. The serum spectroscopic profiles provide a basis to diagnose immunoglobulin disorders or to quantify serum immunoglobulin levels.

Abstract: A hand-operated stick device includes a gripping portion, a working member and an elongated shaft with opposite ends connecting the gripping portion and the working member. The shaft has a wall thickness and at least three ribs projected from an inner side of the shaft. The ribs extend from an end of the shaft adjacent to the gripping portion to the other end adjacent to the working member. The ribs have a width and a height both of which are greater than or equal to the wall thickness. Therefore, it may increase the strength of structure and provide a safe use.

Abstract: A rotary dumbbell of the present invention includes a handle, and two pairs of wheels and weight devices pivoted on opposite ends of the handle for rotation. Each of the wheels has a center pivoted on the handle and is unadjustable in a radial direction thereof that the wheels centrally rotate. Each of the weight devices is adjustable in a radial direction thereof that the weight devices may eccentrically rotate. The dumbbell further includes two pairs of covers to hold the weight devices and the wheels respectively. Therefore, user may get an extra loading because of the eccentric rotation of the weight devices when he/she shakes the dumbbell. The dumbbell may be used as a roller to train abdominal muscles while the wheels serve the function of rollers.

Abstract: The discovery that apolipoprotein B exhibits spectral features in the mid IR spectrum that make it identifiable within blood serum leads to the invented use of a statistical correlation between a concentration of apolipoprotein-B (apoB) in a sample of blood serum and infrared spectral features of the blood serum sample to produce a test for apoB. A method for providing such a test, and tests produced by the method are taught.

Abstract: A method of selecting content to form a content presentation, the presentation comprising an ordered sequence of selected amounts of content, there being a plurality of items of content available for the presentation, the method comprising: (a) for each of the items of content, determining an associated weight-value based, at least in part, on one or more parameters for the presentation; (b) performing a weighted selection of one of the items of content, the selection being weighted in accordance with the weight-values associated with the items of content; (c) selecting at least a part of the content of the selected item of content to be one of the amounts of content in the ordered sequence of selected amounts of content; and (d) repeating steps (a), (b) and (c) until the presentation is complete.